UNSPSC 51284111: Cefpiramide

This classification denotes a cephalosporin antibiotic with the molecular formula C25H24N8O7S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P936YA152N, chemically known as wy 44,635 but generally known as cefpiramide, which bears US NIH Compound Identifier 53130. European Medicines Agency schedules Cefpiramide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07412MIG.

UNSPSC 51284111 Cefpiramide, a Commodity code, does not map to active state and local procurement activity in the recent opportunities available. The code nominally names a specific third-generation cephalosporin antibiotic; however, the recent opportunities tagged to this code show purchases of naloxone, doxycycline hyclate, ciprofloxacin hydrochloride, and drug deactivation systems—none of which are cefpiramide. The mismatch suggests either a data classification error in the source or that tagging practices at the issuing bodies do not align the code with the pharmaceutical products actually being procured under it.

State and local governments appear to use cooperative purchasing vehicles and piggyback contracts to acquire pharmaceutical supplies and medical countermeasures at volume. The issuing bodies in the recent record include the Illinois Department of Public Health and Seminole County, Florida, reflecting activity across both state health departments and county-level health and community services offices. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, for antibiotic tablets over a three-year term, while Seminole County released an IFB on June 30, 2026, for annual purchases of naloxone and drug deactivation systems with quarterly deliveries and a two-year contract term plus renewal option. Absent clear recent activity under the cefpiramide code itself, the code warrants close monitoring for mislabeling patterns or re-classification by issuers.